Genzyme India
SNY
Performance
About Genzyme India
Genzyme India Private Limited is a biotechnology company focused on uncovering and providing transformative therapies for patients suffering from rare and unmet medical needs. Established in 1981 and now a part of Sanofi, Genzyme specializes in treatments for lysosomal storage disorders and has broadened its scope to address conditions like thyroid cancer and multiple sclerosis. With a commitment to patient communities, Genzyme emphasizes collaboration to tailor its research and therapy development, thereby enhancing the quality of care for those it serves.
Recent News
Why Are Medications Administered in Different Forms?
Ocrelizumab Preserves Ambulation, Hand Function in MS
PTAB Denies Institution of One Elevidys® IPR and Institutes Another
Mixed Data Mars Sanofi's Venglustat Programme
Sanofi Names Belén Garijo CEO, Effective May 1, 2026
Bial Drops Pariceract After Phase IIb Failure in GBA-Associated Parkinson’s
‘Orchestra of Therapies’ Required for Most SSc Patients
ElITE 2026 – CHANGE MANAGEMENT CHAMPION – Amy Atwood
Recent Deals
No recent deals for this company.